Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage

Annals of Neurology

Volumn 75, Issue 6, 2014, Pages 876-889

  Wang, Yan Chun ^a   Zhou, Yu ^a   Fang, Huang ^a   Lin, Sen ^b   Wang, Peng Fei ^a   Xiong, Ren Ping ^c   Chen, Jing ^a   Xiong, Xiao Yi ^a   Lv, Feng Lin ^d   Liang, Qiao Li ^e   Yang, Qing Wu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MEDICAL COLLEGE   (China)

^c Research Institute of Surgery   (China)

^d CHONGQING UNIVERSITY   (China)

^e NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYCLOOXYGENASE 2; HEMOGLOBIN; HETERODIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; POLYMYXIN B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN WATER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEK293 CELL LINE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BRAIN EDEMA; CELLS, CULTURED; CEREBRAL HEMORRHAGE; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ENCEPHALITIS; HEK293 CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; NEUROGLIA; NEURONS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84903715703     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24159     Document Type: Article

References (33)

1. Qureshi AI, Mendelow AD, Hanley DF,. Intracerebral haemorrhage. Lancet 2009; 373: 1632-1644.
2. van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010; 9: 167-176.
3. Hwang BY, Appelboom G, Ayer A, et al. Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage. Cerebrovasc Dis 2011; 31: 211-222.
4. Flower O, Smith M,. The acute management of intracerebral hemorrhage. Curr Opin Crit Care 2011; 17: 106-114.
5. Mayer SA, Rincon F,. Treatment of intracerebral haemorrhage. Lancet Neurol 2005; 4: 662-672.
6. Babu R, Bagley JH, Di C, et al. Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention. Neurosurg Focus 2012; 32: E8.
7. Elliott J, Smith M,. The acute management of intracerebral hemorrhage: a clinical review. Anesth Analg 2010; 110: 1419-1427.
8. Zhou Y, Wang Y, Wang J, et al. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol 2014; 115: 25-44.
9. Keep RF, Hua Y, Xi G,. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol 2012; 11: 720-731.
10. Xi G, Keep RF, Hoff JT,. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006; 5: 53-63.
11. Wang J,. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 2010; 92: 463-477.
12. Wang J, Dore S,. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 2007; 27: 894-908.
13. Ducruet AF, Zacharia BE, Hickman ZL, et al. The complement cascade as a therapeutic target in intracerebral hemorrhage. Exp Neurol 2009; 219: 398-403.
14. Akira S, Takeda K,. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
15. Takeda K, Akira S,. Tlr signaling pathways. Semin Immunol 2004; 16: 3-9.
16. Akira S, Uematsu S, Takeuchi O,. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
17. Lin Q, Li M, Fang D, et al. The essential roles of toll-like receptor signaling pathways in sterile inflammatory diseases. Int Immunopharmacol 2011; 11: 1422-1432.
18. Kong Y, Le Y,. Toll-like receptors in inflammation of the central nervous system. Int Immunopharmacol 2011; 11: 1407-1414.
19. Ransohoff RM, Brown MA,. Innate immunity in the central nervous system. J Clin Invest 2012; 122: 1164-1171.
20. Okun E, Griffioen KJ, Mattson MP,. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 2011; 34: 269-281.
21. Lin S, Yin Q, Zhong Q, et al. Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation 2012; 9: 46.
22. Sansing LH, Harris TH, Welsh FA, et al. Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann Neurol 2011; 70: 646-656.
23. Rodriguez-Yanez M, Brea D, Arias S, et al. Increased expression of toll-like receptors 2 and 4 is associated with poor outcome in intracerebral hemorrhage. J Neuroimmunol 2012; 247: 75-80.
24. Wang YC, Wang PF, Fang H, et al. Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury. Stroke 2013; 44: 2545-2552.
25. MacLellan CL, Silasi G, Poon CC, et al. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab 2008; 28: 516-525.
26. Hargus NJ, Thayer SA,. Human immunodeficiency virus-1 tat protein increases the number of inhibitory synapses between hippocampal neurons in culture. J Neurosci 2013; 33: 17908-17920.
27. Mosmann T,. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
28. Lee JK, McCoy MK, Harms AS, et al. Regulator of g-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response. J Neurosci 2008; 28: 8517-8528.
29. Zhao X, Zhang Y, Strong R, et al. 15d-prostaglandin j2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab 2006; 26: 811-820.
30. Ohnishi H, Tochio H, Kato Z, et al. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc Natl Acad Sci U S A 2009; 106: 10260-10265.
31. Li C, Zienkiewicz J, Hawiger J,. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway. J Biol Chem 2005; 280: 26152-26159.
32. Wang YC, Lin S, Yang QW,. Toll-like receptors in cerebral ischemic inflammatory injury. J Neuroinflammation 2011; 8: 134.
33. Jin MS, Lee JO,. Structures of the toll-like receptor family and its ligand complexes. Immunity 2008; 29: 182-191.